Oncological and Survival Outcomes of Pelvic Lymph Node Dissection in Patients with Nonmuscle Invasive Bladder Cancer Undergoing Radical Cystectomy Using the National Cancer Database.
Matthew MoldovanPercival NamYasoda SatpathyLuke WangAditya BagrodiaAmirali SalmasiTyler F StewartIthaar DerweeshJuan Javier-DesLogesPublished in: Clinical genitourinary cancer (2024)
The data suggests an OS benefit in patients with later stage (cT1) NMIBC. Thus, our findings support the existing clinical guidelines of pelvic lymph node dissection in patients with high-risk nonmuscle invasive bladder cancer.
Keyphrases
- rectal cancer
- locally advanced
- muscle invasive bladder cancer
- radical prostatectomy
- robot assisted
- computed tomography
- electronic health record
- lymph node
- prostate cancer
- sentinel lymph node
- neoadjuvant chemotherapy
- image quality
- contrast enhanced
- big data
- dual energy
- magnetic resonance imaging
- squamous cell carcinoma
- adverse drug
- emergency department
- radiation therapy
- early stage
- minimally invasive